It’s a Good Sign a COVID-19 Vaccine Trial Was Paused. Here’s Why

Drugmaker AstraZeneca, which is developing a COVID-19 vaccine in conjunction with the University of Oxford, halted its global phase 3 study on Tuesday after a participant at a site in the United Kingdom developed a suspected adverse reaction.